文章摘要
曹峥,申慧琴.新抗原在结直肠癌中的研究进展[J].安徽医药,2024,28(9):1715-1718.
新抗原在结直肠癌中的研究进展
Advances in neoantigen research in colorectal cancer
  
DOI:10.3969/j.issn.1009-6469.2024.09.005
中文关键词: 结直肠肿瘤  肽类  新抗原  新抗原疫苗  过继细胞疗法  临床试验
英文关键词: Colorectal neoplasms  Peptides  Neoantigens  Neoantigen vaccine  Adoptive cell therapy  Clinical trials
基金项目:
作者单位E-mail
曹峥 山西医科大学第二临床医学院山西太原 030000  
申慧琴 山西医科大学第二医院消化科山西太原 030000 tyshq0003@163.com 
摘要点击次数: 950
全文下载次数: 416
中文摘要:
      目前,结直肠癌有多种治疗策略,包括手术、化疗、放疗和靶向治疗。最新的研究发现,新抗原是一类肿瘤特异性抗原,被视为许多癌症免疫治疗的新靶点。基于新抗原的免疫治疗策略包括肿瘤疫苗和过继细胞疗法,其目的是通过增强宿主 T细胞对新抗原的免疫反应来消除肿瘤细胞。该文总结了目前发现的结直肠癌新抗原及其免疫原性,并列举了基于新抗原治疗结直肠癌的临床试验,最后对当前研究面临的问题与挑战提出思考。
英文摘要:
      At present, there are a variety of treatment strategies for colorectal cancer, including surgery, chemotherapy, radiotherapyand targeted therapy. Recent studies have shown that neoantigens, a class of tumor-specific antigens, are considered new targets for im- munotherapy in many cancers. Neoantigen-based immunotherapeutic strategies include tumor vaccines and adoptive cell therapies,which aim to eliminate tumor cells by enhancing the immune response of host T cells to neoantigens. This paper summarizes the cur-rently identified colorectal cancer neoantigens and their immunogenicity, lists clinical trials of neoantigen-based therapy for colorectal cancer, and concludes with reflections on the issues and challenges facing current research.
查看全文   查看/发表评论  下载PDF阅读器
关闭

分享按钮